ASEAN Supplement & Traditional-Medicine FrameworkASEAN National Supplement Regulatory Frameworks and Harmonisation
The ASEAN Agreement on Health Supplements establishes a harmonised regulatory framework across Southeast Asia, aiming to reduce technical barriers to trade through common standards for ingredients, claims, labelling, and Good Manufacturing Practice.

On this page · 10 sections
- 1The Vision for a Single ASEAN Supplement Market
- 2Defining Health Supplements in the ASEAN Context
- 3The Ten Technical Annexes: The Pillars of Harmonisation
- 4Navigating Claims: Three Levels of Communication
- 5ASEAN GMP: Ensuring Manufacturing Quality
- 6Annex IX: Harmonised Labelling and Consumer Protection
- 7The Reality Check: National Implementation and Differences
- 8Building a Strategic Export Checklist
- 9Compliance Excellence: Adopting Clear Terminology
- 10The Future of ASEAN Supplement Regulation
How does ASEAN Supplement & Traditional-Medicine Framework apply to your shop floor?
Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.
01The Vision for a Single ASEAN Supplement Market
The Association of Southeast Asian Nations (ASEAN) represents one of the world's most dynamic markets for health supplements, driven by a growing middle class, an ageing population, and a deep-rooted cultural affinity for traditional wellness products. However, for decades, the 'single market' vision of the ASEAN Economic Community (AEC) was hampered by a fragmented regulatory landscape. Each of the ten member states—Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam—historically maintained its own set of definitions, ingredient lists, and labelling rules for supplements.
To address these technical barriers to trade, the ASEAN Consultative Committee on Standards and Quality (ACCSQ) established the Traditional Medicines and Health Supplements Product Working Group (TMHS PWG) in 2004. The primary objective was to develop the ASEAN Agreement on the Regulatory Framework for Health Supplements. This agreement aims to ensure that products sold within the region meet high standards of safety, quality, and efficacy while facilitating the free flow of goods through mutual recognition and harmonised technical requirements.
The framework does not replace national authorities but provides a unified set of ten technical annexes that member states agree to transpose into their local laws. For manufacturers and exporters, this offers a path toward greater predictability, though the transition remains complex due to varying speeds of national implementation and the persistence of country-specific requirements.
02Defining Health Supplements in the ASEAN Context
A fundamental challenge in harmonisation is reaching a common definition. Under the ASEAN framework, Health Supplements (HS) are defined as products used to supplement a diet and to maintain, enhance, and improve the healthy function of the human body. Crucially, the definition encompasses vitamins, minerals, amino acids, fatty acids, enzymes, probiotics, and bioactive substances, as well as substances derived from natural sources (animal, mineral, botanical) in the form of extracts or isolates.
The framework explicitly excludes sterile preparations, such as injectables or eye drops, which are typically regulated as pharmaceutical drugs. The intended administration is in small unit doses, such as capsules, tablets, powders, or liquids. This distinction is vital because it separates supplements from both conventional 'functional' foods and therapeutic medicinal products, though the boundary between 'Health Supplements' and 'Traditional Medicines' can sometimes blur depending on the active ingredients and claims made.
- Vitamins and minerals for dietary supplementation.
- Bioactive substances and isolates from natural sources.
- Probiotics and enzymes to support bodily functions.
- Dosage forms limited to oral delivery (non-sterile).
03The Ten Technical Annexes: The Pillars of Harmonisation
The framework is built upon ten specific technical annexes that define the operational requirements for any firm operating in the ASEAN market. These annexes cover the entire product lifecycle, from ingredient selection to post-market monitoring.
Annex I (Negative List): This annex lists substances that are prohibited in health supplements across all member states. It includes potent medicinal substances, toxic botanicals, and ingredients that pose an unacceptable risk to public health. The list is dynamic and managed by the ASEAN TMHS Scientific Committee (ATSC).
Annex II (Additives and Excipients): Defines the 'positive list' of permitted non-active ingredients, such as binders, fillers, and preservatives. It aligns closely with international standards like Codex Alimentarius but includes specific regional considerations for Southeast Asian formulations.
Annex III (Contaminant Limits): Sets unified limits for heavy metals (Arsenic, Cadmium, Lead, Mercury), microbial contamination (e.g., E. coli, Salmonella), and other impurities. This ensures that a product meeting these limits in one country is technically acceptable in others, assuming the test methods are also harmonised.
Annex IV (Minimising TSE Risk): Specifically addresses the risk of Transmissible Spongiform Encephalopathies (TSE) from animal-derived ingredients, requiring manufacturers to provide evidence of safe sourcing for materials like gelatine or stearates.
Annex V (Stability and Shelf-Life): Establishes the requirements for stability testing, including the use of Climatic Zone IVb (Hot and Humid) conditions, which are standard for the ASEAN region (30°C / 75% RH).
Annex VI (Safety Substantiation): Outlines the evidence required to demonstrate that a supplement is safe for human consumption. This includes historical use data, toxicological studies, and clinical evidence where necessary.
Annex VII (Claims and Claims Substantiation): Perhaps the most critical for marketing, this annex defines the types of permitted claims and the evidence needed to support them.
Annex VIII (GMP Requirements): The ASEAN Guidelines on Good Manufacturing Practice for Health Supplements. This is a comprehensive set of standards for facilities, personnel, documentation, and quality control.
Annex IX (Labelling Requirements): Standardises the information that must appear on product packaging, including mandatory warning statements and language requirements.
Annex X (Maximum Levels for Vitamins and Minerals): Sets the upper limits for micronutrients to prevent overconsumption while ensuring efficacy.
04Navigating Claims: Three Levels of Communication
The ASEAN Guidelines on Claims and Claims Substantiation (Annex VII) categorise claims into three distinct tiers, each requiring a different level of scientific evidence. This tiered approach is designed to protect consumers from misleading information while allowing firms to communicate the benefits of their products.
1. General Health Claims: These are broad statements about maintaining good health or improving a healthy function (e.g., 'Supports immune health'). They typically require a lower threshold of evidence, often based on well-established scientific literature or historical use.
2. Nutrient Function Claims: These describe the physiological role of a nutrient in growth, development, and normal functions of the body (e.g., 'Calcium is necessary for bone health'). These claims are usually pre-approved based on international consensus (e.g., WHO or Codex) and do not require extensive new studies if the nutrient level meets the required threshold.
3. Disease Risk Reduction Claims: These are the most sensitive and relate the consumption of a supplement to the reduced risk of developing a disease or health-related condition (e.g., 'Reducing sodium intake may reduce the risk of hypertension'). These require the highest level of evidence, including systematic reviews and double-blind clinical trials, and must be explicitly authorised by national regulators.
05ASEAN GMP: Ensuring Manufacturing Quality
The ASEAN GMP Guidelines (Annex VIII) represent the operational backbone of the framework. Unlike some older national standards that were merely descriptive, ASEAN GMP is prescriptive and requires a robust quality management system (QMS). It emphasizes that quality cannot be 'tested into' a product; it must be built into the entire manufacturing process.
Key components of ASEAN GMP include personnel training, facility design that prevents cross-contamination, equipment qualification, and comprehensive documentation. Master Production Records (MPR) and Batch Production Records (BPR) must be meticulously maintained to ensure traceability from the raw material supplier to the final consumer.
One of the most significant aspects of the harmonisation is the move toward mutual recognition of GMP certificates. If a manufacturer is licensed by a recognized ASEAN authority (such as Malaysia's NPRA or Singapore's HSA) following the ASEAN GMP standards, other member states are encouraged to accept that evidence of compliance, reducing the need for redundant site inspections. However, this mutual recognition is still in the process of being implemented and varies by country pair.
Digital systems are increasingly used to manage these complex QMS requirements. While the framework does not mandate specific software, it expects that any system used for electronic records or signatures provides data integrity, audit trails, and security equivalent to paper-based systems.
06Annex IX: Harmonised Labelling and Consumer Protection
Labelling is the primary interface between the product and the consumer. Annex IX ensures that essential information is clear and accessible. Mandatory elements on an ASEAN-aligned label include the product name, dosage form, list of active ingredients and their strengths, recommended dosage, storage conditions, and the name and address of the manufacturer or distributor.
A unique challenge in ASEAN is language. While the technical annexes provide a framework, most member states require the label to be in their national language (e.g., Bahasa Indonesia for Indonesia, Thai for Thailand). This often necessitates multi-lingual labels or country-specific packaging, which can increase complexity for regional distributors.
Furthermore, the framework requires specific warning statements for certain ingredients. For instance, products containing bee pollen or royal jelly must carry warnings about potential allergic reactions. Manufacturers must ensure these statements are prominent and follow the exact wording prescribed by each member state's transposition of the annex.
07The Reality Check: National Implementation and Differences
Despite the high degree of technical agreement, the 'ASEAN Single Market' for supplements is not yet a reality. The process of transposition—whereby regional guidelines become national law—is uneven. Exporters must navigate the nuances of each market, as national authorities often retain specific requirements that are not yet covered by the harmonised annexes.
For example, Singapore (HSA) has been a leader in adopting the harmonised standards, often using them as a baseline for their risk-based regulatory approach. In contrast, Indonesia (BPOM) maintains a very rigorous pre-market registration system that includes mandatory local lab testing for every batch of certain imported products. Thailand (Thai FDA) has specific requirements for the 'format' of stability data that may go beyond the basic ASEAN Annex V.
Another area of divergence is the 'Positive List' for vitamins and minerals. While Annex X sets maximum levels, some countries may set lower 'Recommended Dietary Allowances' (RDA) that effectively act as caps for general-sale supplements. If a product exceeds these levels, it may be restricted to 'Pharmacy Only' sale or require registration as a medicinal product.
08Building a Strategic Export Checklist
Successfully launching a health supplement across the ASEAN region requires a dual-track strategy: alignment with the ASEAN harmonised framework for core quality and safety, followed by a targeted assessment of national differences.
- Confirm Ingredient Alignment: Cross-reference every active and inactive ingredient against the ASEAN Negative List (Annex I) and the target country's specific prohibited lists.
- Verify Vitamin/Mineral Levels: Ensure that dosages do not exceed the maximum levels defined in Annex X or the specific RDA caps of the target market.
- Stability Testing at Zone IVb: Ensure that stability data is generated at 30°C / 75% RH. Data from Zone II (temperate) is generally not accepted for registration in the ASEAN region.
- Claims Substantiation Audit: Review all marketing claims against the Annex VII criteria. Ensure that any 'high-level' claims are supported by the specific clinical evidence required by the target country's regulator.
- Language and Labelling Compliance: Develop a labelling strategy that accounts for local language requirements and the specific warning statements mandated by national law.
- GMP Certification: Obtain a GMP certificate from a recognized authority that references the ASEAN GMP guidelines. This is often the first document requested during the registration process.
Firms should also consider the 'Product Classification' phase. In some markets, a product might be classified as a 'Health Supplement,' while in others, it might fall under 'Traditional Medicine' or even 'Food.' This classification dictates the registration path, the time to market, and the permissible claims.
09Compliance Excellence: Adopting Clear Terminology
Maintaining a strong regulatory posture requires moving away from absolute or marketing-heavy language toward evidence-based technical descriptions. Regulatory authorities in the ASEAN region are increasingly vigilant about over-promising in both product labels and digital marketing.
Terms that suggest an absolute assurance of safety or efficacy are routinely flagged for correction. Instead, firms should focus on ensuring safety through rigorous adherence to the harmonised annexes. Similarly, claims of total regulatory alignment are often viewed with skepticism unless backed by specific audit records and registration certificates for the exact batch in question. The focus should be on demonstrating that the product meets all applicable specifications defined in the framework.
Operations must also avoid relying on unmediated release of batches. In a GMP environment, every batch must be reviewed and released by an authorised person (or a validated system following specific logic) based on actual test results and production logs. The quality unit's role is to provide the final oversight that ensures the product is fit for the market.
Managed inventory movement and monitored storage operations are essential to protect the integrity of the product during its time in the supply chain. This is particularly critical in the ASEAN region, where high ambient humidity can rapidly degrade supplement quality if storage conditions are not strictly maintained and documented.
10The Future of ASEAN Supplement Regulation
The roadmap for ASEAN harmonisation is long, but the trajectory is clear. As more member states transpose the technical annexes, the cost of doing business across borders will decrease. We expect to see more Mutual Recognition Arrangements (MRAs) for GMP inspections and potentially for product registrations, although the latter remains a distant goal.
Technological trends, such as the use of blockchain for ingredient traceability and AI-driven compliance monitoring, will likely be integrated into the framework in future updates. The ASEAN TMHS Scientific Committee continues to meet regularly to update the ingredient lists and refine the guidelines based on new scientific evidence.
For companies, staying informed and active within industry associations (like AAHSA) is the best way to anticipate these changes. By adopting the ASEAN harmonised standards as their baseline, firms can position themselves to be market-ready for any of the ten member states, regardless of the specific speed of local implementation.
Frequently asked questions
Q.What is the primary goal of the ASEAN health supplement framework?+
The primary goal is to harmonise technical requirements and standards across the ten ASEAN member states to reduce technical barriers to trade, ensuring product safety, quality, and efficacy while facilitating the free flow of goods.
Q.Which countries are covered by the ASEAN Agreement on Health Supplements?+
The agreement covers all ten ASEAN member states: Brunei Darussalam, Cambodia, Indonesia, Lao PDR, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Viet Nam.
Q.What are the three types of claims permitted under the ASEAN framework?+
The framework permits General Health Claims, Nutrient Function Claims, and Disease Risk Reduction Claims, with each tier requiring increasing levels of scientific substantiation.
Q.Does the ASEAN framework mean a single registration for all ten countries?+
No. While the technical standards are harmonised, manufacturers must still register their products with the national regulatory authority of each individual country where they intend to sell.
Q.What temperature and humidity are required for stability testing in ASEAN?+
Due to the region's climate, stability testing must be conducted under Climatic Zone IVb conditions, which are 30°C and 75% relative humidity.
Primary sources
- ASEAN Guidelines on Claims and Claims Substantiation for Health Supplements
- ASEAN Guidelines on Labelling Requirements for Health Supplements
- AAHSA - ASEAN Technical Guidelines Summary
- HSA Singapore - ASEAN Harmonisation of TM and HS
- NutraIngredients-Asia - ASEAN Harmonisation Delay Analysis
- RAPS - ASEAN Harmonization of Technical Standards - Industry Perspective
Further reading
Want to see how ASEAN Supplement & Traditional-Medicine Framework could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.
